Accelerated Disease Control Initiatives ( ADC)
Accelerated disease control focuses on reducing childhood morbidity and mortality from vaccine preventable diseases such as Polio, Measles, Maternal & Neonatal Tetanus and Yellow Fever , by using intensive strategies to reach all at risk populations. These initiatives rely on strong surveillance and the use of disease impact indicators to drive activities. By their very nature, ADCs are time-limited, focused efforts.

Accelerated Development and Introduction Plans ( see Pneumo ADIP and Rotavirus Vaccine Program) ADIPs
In June 2002, the GAVI Board endorsed the creation of Accelerated Development and Introduction Plans (ADIPs), designed to address the significant challenges involved in making available new vaccines that are used primarily in developing countries.

The two projects endorsed were: The Rotavirus ADIP proposal based at PATH and the Pneumococcal ADIP proposal based at John Hopkins Bloomberg School of Public Health.

Annual Progress Report
An annual progress report is required of countries receiving support from the Vaccine Fund. It is submitted annually to the GAVI Secretariat together with a copy of the Joint Reporting Form. The report should provide a comprehensive picture of a country’s progress over time, annual targets and related requests for GAVI support.

Antigen
An antigen is the active component of a vaccine that stimulates the body to produce antibodies which fight off disease.

Auto-disable syringes ( AD syringes)
Syringes that have a blocking mechanism to prevent their re-use.

As of December 2004 GAVI has supplied 991 million single-use auto-disable syringes for immunization.